関連する実験動画

Updated: May 5, 2026

Establishing Intracranial Brain Tumor Xenografts With Subsequent Analysis of Tumor Growth and Response to Therapy using Bioluminescence Imaging
11:09

Establishing Intracranial Brain Tumor Xenografts With Subsequent Analysis of Tumor Growth and Response to Therapy using Bioluminescence Imaging

Published on: July 14, 2010

41.4K

再発性/不治性ニューロブラストーマに対するナキシタマブ.

Teresa Herriage1, Jawhar Rawwas1, Adam Sterman2

  • 1Cancer and Blood Disorders Program, Children's Minnesota, Minneapolis, MN, USA.

Journal of pediatric hematology/oncology nursing
|February 19, 2026
PubMed
まとめ

ナキサタマブ免疫療法は,再発性/耐性神経芽細胞腫の治療のために,門診で安全に投与することができます. インターディシピナリなチームアプローチは,有害事象を効果的に管理し,患者は治療を受け,同じ日に自宅に戻ることができます.

キーワード:
薬剤の投与管理について神経芽細胞腫とは介護の介護は介護の介護である.腫瘍学 診断 診断固体腫瘍は,固体腫瘍である.ターゲットを絞った治療法です.

さらに関連する動画

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

29.3K
An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas03:53

An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas

Published on: October 10, 2025

696

関連する概念動画

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.7K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
827